2.16
+0.02(+0.93%)
Currency In USD
| Previous Close | 2.14 |
| Open | 2.11 |
| Day High | 2.19 |
| Day Low | 2.11 |
| 52-Week High | 840 |
| 52-Week Low | 1.95 |
| Volume | 35,073 |
| Average Volume | 1M |
| Market Cap | 2.97M |
| PE | -0.23 |
| EPS | -9.44 |
| Moving Average 50 Days | 2.31 |
| Moving Average 200 Days | 45.09 |
| Change | 0.02 |
PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue
GlobeNewswire Inc.
Jun 24, 2025 12:30 PM GMT
Serves Multiple Tier-1 Aerospace Clients AS9100 and ISO 9001-Certified CNC Manufacturer NEWPORT BEACH, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (the “Company,” “PMGC,” “we,” or “us”), a diversified public holding
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
GlobeNewswire Inc.
Jun 18, 2025 1:52 PM GMT
NEWPORT BEACH, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital”), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), today issued a public statement urging Alaunos Therapeutics, Inc. (NASDAQ: TCRT) to accept a
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
GlobeNewswire Inc.
Jun 17, 2025 1:04 PM GMT
Northstrive Biosciences and Yuva Biosciences previously announced a collaboration leveraging MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for